Pharmaceutical giant AbbVie yesterday became the first drugmaker to file suit against Missouri’s new law prohibiting 340B contract pharmacy restrictions [...] …
Category: Judicial
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The West Virginia attorney general and multiple hospital groups recently urged a federal district judge to deny Novartis’ motion to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Federal Judge Denies Drugmakers’ Bids to Block Mississippi’s New 340B Contract Pharmacy Access Law
A federal district judge has rejected two drug industry attempts to block Mississippi’s new state law prohibiting drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...] …